Deutsche Bank Ag\ Pro Phase Labs, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.95 - $3.27 $55,460 - $61,476	-18,800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.94 - $3.23 $3,819 - $4,195	-1,299 Reduced 6.46%	18,800 $56,000
Q2 2018 Aug 14, 2018	BUY	$2.84 - $5.41 $57,081 - $108,735	20,099 New	20,099 $65,000
Q1 2018 May 15, 2018	SELL	$2.24 - $3.21 $41,767 - $59,853	-18,646 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.05 - $2.3 $8,577 - $9,623	4,184 Added 28.93%	18,646 $40,000
Q3 2017 Nov 14, 2017	BUY	$2.03 - $2.29 $29,357 - $33,117	14,462	14,462 $30,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.4M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.